Precision Medicine Market: Current Analysis and Forecast (2020-2026)

Precision Medicine Market: Current Analysis and Forecast (2020-2026)

Emphasis on Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others), Disease Area (Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Others), End-user (Hospitals & Clinics, Pharmaceuticals, Diagnostic Companies, Healthcare IT Firms, Others) and Region/Country

$ 5,000
$6,500
$8,450

Published: Dec-2019

Pages:XX

Table:XX

Figure:XX

Report ID:UMHE20156

Precision medicine (PM) is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. Personalized nanomedicine involving individualized drug selection and dosage profiling in combination with clinical and molecular biomarkers can ensure the maximal efficacy and safety of the treatment. The major hindrance toward the development of such therapies is the handling of the “Big Data,” to keep the databases updated. Robust automated data mining tools are being developed to extract information regarding genes, variations, and their association with diseases. Phenotyping, an integral part of PM, is aimed at translating the data generated at cellular and molecular levels into clinically relevant information. Precision Medicine Moves Care from Population-Based Protocols to Truly Individualized Medicine as President of the US announced the Precision Medicine Initiative in his 2015 State of the Union address. Under the initiative, medical care would transition from a one-size-fits-all approach to an individualized approach, in which data on each patient’s genomic makeup, environment, and lifestyle (the exposome) helps medical professionals tailor treatment and prevention strategies. To achieve the Precision Medicine Initiative mission statement, “to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care,” researchers and clinicians need vast and varied amounts of data and the technology to ensure that data is widely accessible and usable.

Annual Incidence of Common Adult-Onset Neurologic Disorders, United States, 2018

Insights Presented in the Report

  • Based on technology type, the market is fragmented into big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. Recent technological and analytical advances in genomics, have now made it possible to rapidly identify and interpret the genetic variation underlying a single patient’s disease, thereby providing a window into patient-specific mechanisms that cause or contribute to disease, which could ultimately enable the ‘precise’ targeting of these mechanisms
  • Based on the market segment by application type, the market is segmented into oncology, respiratory diseases, central nervous system disorders, immunology, genetic diseases and others. With the advent of precision medicine, cancer treatment is moving from a paradigm in which treatment decision is primarily based on tumor location and histology followed by molecular information to a new paradigm whereby treatment decisions will be primarily based on molecular information followed by histology and tumor location
  • Based on the market segment by end-user, the market is fragmented into hospitals & clinics, pharmaceuticals, diagnostic companies, Healthcare-IT firms and others. The precision medicine suppliers that understand technology and the goals of value-based healthcare can create value in the precision medicine value-chain by offering value-based solutions and platforms to interpret and connect data points. There are a number of technology companies who work in the field of precision medicine and more will be founded in the years to come
  • For better understanding on the market dynamics of Precision Medicine market, detailed analysis was conducted for different countries in the region including North America (United States, Canada, Mexico and Rest of North America), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, Australia, India and Rest of APAC), and Rest of World
  • Some of the major players operating in the market include Hoffmann-La Roche, Medtronic, Qiagen, Illumina, Abbott Laboratories, GE Healthcare, NanoString Technologies, bioMérieux SA, Danaher Corporation, and AstraZeneca

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends and opportunities prevailing in the industry.
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

Precision Medicine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

CHAPTER 1          MARKET INTRODUCTION                                            

                                1.1          Market Definition                           

                                1.2          Objective of the Study                 

                                1.3          Limitation                           

                                1.4          Stakeholders                    

                                1.5          Currency used in the Report

                                1.6          Scope of the Report                      

CHAPTER 2          RESEARCH METHODOLOGY OR ASSUMPTION                                   

                                2.1          Research Methodology for Precision Medicine Market Study

                                                2.1.1      Main objective of the Precision Medicine Market Study

CHAPTER 3          REGULATORY FRAMEWORK                                      

CHAPTER 4          INDUSTRY AT A GLANCE                                              

CHAPTER 5          EXECUTIVE SUMMARY                                 

CHAPTER 6          MARKET OVERVIEW                                      

                                6.1          Introduction                                                     

                                6.2          Market Drivers

                                                6.2.1      Rise in demand for preventive care

                                                6.2.2      Advancements in sequencing technologies

                                                6.2.3      Shift from treatment-based to preventive healthcare

                                6.3          Market Restraints

                                                6.3.1      Unstable legal and regulatory framework            

                                                6.3.2      Lack of access to relevant data

                                6.4          Market Opportunities

                                                6.4.1      Targeted gene therapies

                                                6.4.2      Rising awareness regarding modified medications along with lifestyle changes  

                                6.5          Factor Analysis (Demand & Supply)

                                                6.5.1      Demand Side Analysis

                                                6.5.2      Supply Side Analysis      

                                                                6.5.2.1   Top Partnerships

                                                                6.5.2.2   Top Mergers& Acquisitions

                                                                6.5.2.3   Top Funding

                                                                6.5.2.4   Top Business Expansions

                                                                6.5.2.5   Top Product Launches

                                                                6.5.2.6   Top Start ups

                                6.6          Value Chain Analysis    

CHAPTER 7          MARKET INSIGHTS, BY TECHNOLOGY (US$)                       

                                7.1          General Introduction

                                                7.1.1 Big Data Analytics

                                                7.1.2 Bioinformatics

                                                7.1.3 Gene Sequencing

                                                7.1.4 Drug Discovery

                                                7.1.5 Companion Diagnostics

                                                7.1.6 Others

CHAPTER 8          MARKET INSIGHTS, BY DISEASE AREA (US$)                       

                                8.1          General Introduction                    

                                                8.1.1      Oncology            

                                                8.1.2      Respiratory Diseases

                                                8.1.3      Central Nervous System Disorders

                                                8.1.4      Immunology

                                                8.1.5      Genetic Diseases

                                                8.1.6      Others

CHAPTER 9          MARKET INSIGHTS, BY END USER (US$)                

                                9.1          General Introduction                    

                                                9.1.1      Hospitals & Clinics           

                                                9.1.2      Pharmaceuticals

                                                9.1.3      Diagnostic Companies

                                                9.1.4      Healthcare IT Firms

                                                9.1.5      Others

CHAPTER 10       MARKET INSIGHTS, BY REGION                                

                                10.1        North America Precision Medicine Market

                                                10.1.1    United States

                                                10.1.2    Canada

                                                10.1.3    Mexico

                                                10.1.4    Rest of North America

                                10.2        Europe Precision Medicine Market

                                                10.2.1    Germany

                                                10.2.2    United Kingdom

                                                10.2.3    France

                                                10.2.4    Italy

                                                10.2.5    Spain

                                                10.2.6    Rest of Europe

                                10.3        Asia-Pacific Precision Medicine Market

                                                10.3.1    China

                                                10.3.2    Japan

                                                10.3.3    Australia

                                                10.3.3    India

                                                10.3.4    Rest of APAC

                                10.4        Rest of World Precision Medicine Market

CHAPTER 11       COMPETITIVE SCENARIO                                             

                                11.1        Porter’s Five forces analysis                      

                                                11.1.1    Bargaining power of Buyer         

                                                11.1.2    Bargaining power of Supplier     

                                                11.1.3    Threat of new entrants

                                                11.1.4    Availability of Substitute              

                                                11.1.5    Industry Rivalry

                                11.2        Market Share Analysis, by Company, 2018                          

                                                11.2.1    Global Precision Medicine Market Share of Major Players, 2018

CHAPTER 12       TOP 10 COMPANY PROFILES                                      

                                12.1        Hoffmann-La Roche                      

                                                12.1.1    Key Facts            

                                                12.1.2    Business Description     

                                                12.1.3    Key Product/Application Offerings          

                                                12.1.4    SWOT Analysis 

                                                12.1.5    Key Financials   

                                                                10.1.5.1 Revenue Split by Region

                                                                10.1.5.2 Revenue Split by Products

                                                12.1.6    Recent Developments

                                                                10.1.6.1 Product Launches

                                                                10.1.6.2 Strategic Alliance

                                                                10.1.6.3 Business Expansion

                                                                10.1.6.4 Merger & Acquisition   

                                12.2        Medtronic                         

                                12.3        Qiagen                

                                12.4        Illumina                              

                                12.5        Abbott Laboratories                      

                                12.6        GE Healthcare                  

                                12.7        NanoString Technologies                            

                                12.8        bioMérieux SA                

                                12.9        Danaher Corporation                    

                                12.10      AstraZeneca                      

                               

Note: Information Related to financials and product-specific recent development would depend on data availability. Also, this is a tentative table of content and can be changed as per your requirement

Analyzing historical market, estimation of the current market and forecasting the future market for the Precision Medicine Market will be based on the three major steps undertaken to create and analyze the adoption trend of precision medicine market across various industry verticals in the different region around the globe. Exhaustive secondary research would also be conducted to collect the historical market numbers to estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions would be taken into consideration. Moreover, exhaustive primary interviews would also be conducted with industry experts across the value chain of the precision medicine market. Post assumption and validation of market numbers through primary interviews, bottom-up approach will be employed to forecast the complete market size of the precision medicine market. Thereafter, market breakdown and data triangulation methods would be adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study would be conducted to obtain the historical market size of the precision medicine market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the precision medicine market, a detailed secondary analysis would be conducted to gather historical market insights and share for different segments & sub-segments for major regions across the world. Major segments included in the report as technology, application and end-user. Further analysis would also be done for different countries to analyze the overall adoption of the precision medicine in that particular country.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, detailed factor analysis was conducted to estimate the current market size of the precision medicine market. Factor analysis would be conducted using dependent and independent variables such as rise in demand for preventive care, shift from treatment-based to preventive healthcare, advancements in sequencing technologies, rising awareness regarding modified medications along with lifestyle changes and targeted gene therapies. The demand and supply-side scenario would also be thoroughly studied by considering top partnerships, merger and acquisition, business expansion, product launches and analyzing the list of start-ups in the precision medicine market across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we would arrive at the current market size, key players in the precision medicine market and market shares of these players. All the required percentage shares split, and market breakdowns would be determined using the above-mentioned secondary approach and will be verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weight would be assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up approach would be applied to arrive at the market forecast pertaining to 2026 for different segments and sub-segments across the different regions of the world. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and penetration rate of precision medicine across the major regions
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the precision medicine market in terms of the services offered as well as market share. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews would be conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings will then be summarized, and statistical analysis would be performed to prove the stated hypothesis. Inputs from primary research would be consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique would be employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the precision medicine market globally. Data will split into several segments & sub-segments post studying various parameters and trends in the areas of technology, application and end-user of precision medicine market.

Main objective of the Precision Medicine Market Study

The current & future market trends of the precision medicine would be pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the precision medicine in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include technology, application and end-user
  • Define and analysis of the regulatory framework for precision medicine
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors pertaining to the industry
  • Analyze the current and forecast market size of the precision medicine market for the major regions. Major regions studied in the report include North America, Europe, Asia-Pacific and Rest of the World. Country-level analysis is also conducted in the report
  • Define and analyze the competitive landscape of the precision medicine market and the growth strategies adopted by the market players to sustain in the fast-growing market

Analyzing historical market, estimation of the current market and forecasting the future market for the Precision Medicine Market will be based on the three major steps undertaken to create and analyze the adoption trend of precision medicine market across various industry verticals in the different region around the globe. Exhaustive secondary research would also be conducted to collect the historical market numbers to estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions would be taken into consideration. Moreover, exhaustive primary interviews would also be conducted with industry experts across the value chain of the precision medicine market. Post assumption and validation of market numbers through primary interviews, bottom-up approach will be employed to forecast the complete market size of the precision medicine market. Thereafter, market breakdown and data triangulation methods would be adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study would be conducted to obtain the historical market size of the precision medicine market through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the precision medicine market, a detailed secondary analysis would be conducted to gather historical market insights and share for different segments & sub-segments for major regions across the world. Major segments included in the report as technology, application and end-user. Further analysis would also be done for different countries to analyze the overall adoption of the precision medicine in that particular country.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, detailed factor analysis was conducted to estimate the current market size of the precision medicine market. Factor analysis would be conducted using dependent and independent variables such as rise in demand for preventive care, shift from treatment-based to preventive healthcare, advancements in sequencing technologies, rising awareness regarding modified medications along with lifestyle changes and targeted gene therapies. The demand and supply-side scenario would also be thoroughly studied by considering top partnerships, merger and acquisition, business expansion, product launches and analyzing the list of start-ups in the precision medicine market across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we would arrive at the current market size, key players in the precision medicine market and market shares of these players. All the required percentage shares split, and market breakdowns would be determined using the above-mentioned secondary approach and will be verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weight would be assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up approach would be applied to arrive at the market forecast pertaining to 2026 for different segments and sub-segments across the different regions of the world. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and penetration rate of precision medicine across the major regions
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the precision medicine market in terms of the services offered as well as market share. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews would be conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings will then be summarized, and statistical analysis would be performed to prove the stated hypothesis. Inputs from primary research would be consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique would be employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the precision medicine market globally. Data will split into several segments & sub-segments post studying various parameters and trends in the areas of technology, application and end-user of precision medicine market.

Main objective of the Precision Medicine Market Study

The current & future market trends of the precision medicine would be pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the precision medicine in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include technology, application and end-user
  • Define and analysis of the regulatory framework for precision medicine
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors pertaining to the industry
  • Analyze the current and forecast market size of the precision medicine market for the major regions. Major regions studied in the report include North America, Europe, Asia-Pacific and Rest of the World. Country-level analysis is also conducted in the report
  • Define and analyze the competitive landscape of the precision medicine market and the growth strategies adopted by the market players to sustain in the fast-growing market

Precision Medicine Market: Current Analysis and Forecast (2020-2026)